These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 4924275

  • 1. [Biochemical bases for the treatment of Parkinson's syndrome with L-dopa].
    Pletscher A, Bartholini G, Gey KF, Jenni A.
    Schweiz Med Wochenschr; 1970 May 09; 100(19):797-804. PubMed ID: 4924275
    [No Abstract] [Full Text] [Related]

  • 2. [Current treatment of Parkinson syndrome with L-dopa].
    Gerstendbrand F, Gründig E, Musiol A.
    Pol Tyg Lek; 1972 May 22; 27(21):798-800. PubMed ID: 4555002
    [No Abstract] [Full Text] [Related]

  • 3. [10 years of L-DOPA therapy of Parkinson's syndrome].
    Birkmayer W.
    Wien Klin Wochenschr; 1971 Apr 02; 83(13):221-7. PubMed ID: 4254333
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of Parkinson's syndrome with L-dopa].
    Kaeser HE, Ferel D, Wurmser P.
    Schweiz Med Wochenschr; 1970 May 09; 100(19):805-13. PubMed ID: 4924276
    [No Abstract] [Full Text] [Related]

  • 5. Dopaminergic nervous transmission in Parkinson's disease.
    Rinne UK, Sonninen V, Riekkinen P, Laaksonen H.
    Med Biol; 1974 Jun 09; 52(3):208-17. PubMed ID: 4371255
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of Parkinson's disease with L-dopa].
    Guglielmi L, Vecchi L.
    Clin Ter; 1970 May 15; 53(3):259-69. PubMed ID: 4917328
    [No Abstract] [Full Text] [Related]

  • 7. Levodopa (Larodopa). For the relief of symptoms associated with Parkinson's disease and syndrome.
    Clin Pharmacol Ther; 1970 May 15; 11(6):921-4. PubMed ID: 4921295
    [No Abstract] [Full Text] [Related]

  • 8. Levodopa in Parkinsonism.
    Weiss JL, Chase TN.
    Drugs; 1971 May 15; 2(4):257-61. PubMed ID: 4948349
    [No Abstract] [Full Text] [Related]

  • 9. L-dopa: its effect on the cardiovascular system.
    Carrasco HA, Lozano J, Lang TW, Meerbaum S.
    Geriatrics; 1971 Sep 15; 26(9):100-8. PubMed ID: 5125691
    [No Abstract] [Full Text] [Related]

  • 10. L-dopa in Parkinson's disease. A report on 95 cases and review of the literature.
    Lewis I.
    J Med Assoc State Ala; 1971 May 15; 40(11):709-18. PubMed ID: 5573008
    [No Abstract] [Full Text] [Related]

  • 11. [Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].
    Ferel D.
    Schweiz Med Wochenschr; 1972 Jan 22; 102(3):88-94. PubMed ID: 4551909
    [No Abstract] [Full Text] [Related]

  • 12. Parkinson's syndrome--modern therapy, known facts and unanswered questions.
    Albert E.
    Pharmakopsychiatr Neuropsychopharmakol; 1973 Sep 22; 6(5):229-46. PubMed ID: 4604872
    [No Abstract] [Full Text] [Related]

  • 13. [Study of dopamine and noradrenaline in the brains of three patients with Parkinson's disease who died in the course of treatment with L-dopa].
    Buscaino GA, Sori A, Campanella G.
    Rev Neurol (Paris); 1972 Aug 22; 127(2):301-2. PubMed ID: 4666634
    [No Abstract] [Full Text] [Related]

  • 14. L-dopa therapy in parkinsonism: mechanism of action.
    Sandler M.
    Psychiatr Neurol Neurochir; 1971 Aug 22; 74(4):331-3. PubMed ID: 5146239
    [No Abstract] [Full Text] [Related]

  • 15. Cerebral catecholamine concentration after L-dopa therapy in Parkinson's disease.
    Greer M, Anton AH.
    Trans Am Neurol Assoc; 1970 Aug 22; 95():247-8. PubMed ID: 4328099
    [No Abstract] [Full Text] [Related]

  • 16. [L-Dopa in Parkinson's-syndrome. New therapeutic attack?].
    Brockmann AW.
    Ther Ggw; 1970 Nov 22; 109(11):1590-3. PubMed ID: 5486128
    [No Abstract] [Full Text] [Related]

  • 17. L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients.
    Goodwin FK, Murphy DL, Brodie HK, Bunney WE.
    Biol Psychiatry; 1970 Oct 22; 2(4):341-66. PubMed ID: 4920729
    [No Abstract] [Full Text] [Related]

  • 18. Alpha-methyldopa as an adjunct to levodopa treatment of Parkinson's disease.
    Sweet RD, Lee JE, McDowell F.
    Trans Am Neurol Assoc; 1971 Oct 22; 96():59-65. PubMed ID: 5159130
    [No Abstract] [Full Text] [Related]

  • 19. Symposium on levodopa in Parkinson's disease. Clinical and pharmacological aspects. Where do we go from here?
    Clin Pharmacol Ther; 1971 Oct 22; 12(2):408-16. PubMed ID: 5577487
    [No Abstract] [Full Text] [Related]

  • 20. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
    Degkwitz R.
    Med Klin; 1969 Aug 15; 64(33):1451-6. PubMed ID: 4896563
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.